Improved approaches in the treatment of complicated bacterial vaginosis and vulvovaginal candidiasis

Strizhakov A.N., Ignatko I.V., Churganova A.A., Bogacheva N.A.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia
Objective. To conduct a comparative analysis of the effectiveness of an improved imidazole derivative (2% clotrimazole cream) as part of complex therapy with standard treatment regimens for the development of bacterial vaginosis and vulvovaginal candidiasis.
Materials and methods. The study included 90 women who had combinations of Atopobium vaginae, Gardnerella vaginalis and Candida krusei. These pathogens caused not only the development of an infectious process in the lower part of the urogenital tract, but also its complicated course.
Results. The study showed that the use of the improved imidazole derivative (2% clotrimazole cream) could arrest the main symptoms of the disease after the first use. The drug is highly effective against difficult-to-cultivate pathogens of bacterial vaginosis and Candida non-albicans, and also does not adversely affect the amount of lactobacilli in vaginal biocenosis.
Conclusion. The experience of using the improved imidazole derivative shows that the drug is no less effective in inflammatory diseases of the lower parts of the urogenital tract than its counterparts. Its purpose is appropriate in the complex therapy of complicated bacterial vaginosis and vulvovaginal candidiasis.

Keywords

bacterial vaginosis
vulvovaginal candidiasis
imidazole derivative

References

1. Абен А.Е., Салыкова А.К., Шигамбекова Н.С., Измайлович М.Р., Скворцова А.В., Кожанова Р.Т., Касымбекова Б.К. Оценка эффективности лечения хронического рецидивирующего вульвовагинального кандидоза иммуномодуляторами в составе комбинированной терапии. В кн.: Материалы IV Международной научно-практической конференции «Новые задачи современной медицины». Санкт-Петербург, 20-23 декабря 2016 г. СПб.; 2016: 25-8. [Aben A.E., Salykova A.K., Shigambekova N.S., Izmailovich MR, Skvortsova A.V., Kozhanova R.T., Kasymbekova B.K. Evaluation of the effectiveness of treatment of chronic recurrent vulvovaginal candidiasis by immunomodulators as part of combination therapy. In: Materials of the IV International Scientific and Practical Conference “New Problems of Modern Medicine.” St. Petersburg, December 20-23, 2016 St. Petersburg; 2016: 25-8. (in Russian)]

2. Веселов А.В., Козлов Р.С. Инвазивный кандидоз: современные аспекты эпидемиологии, диагностики, терапии и профилактики у различных категорий пациентов (в вопросах и ответах). Клиническая микробиология и антимикробная химиотерапия. 2016; 18(2, Приложение): 1-105. [Veselov A.V., Kozlov R.S. Invasive candidiasis: modern aspects of epidemiology, diagnosis, treatment and prevention in various categories of patients (in questions and answers). Clinical microbiology and antimicrobial chemotherapy. 2016; 18 (2, Appendix): 1-105. (in Russian)]

3. Зароченцева Н.В., Белая Ю.М. Проблема урогенитального кандидоза у женщин в современном мире. РМЖ. 2016; 24(15): 976-81. [Zarochentseva N.V., Belaya Yu.M. The problem of urogenital candidiasis in women in the modern world. Breast cancer 2016; 24 (15): 976-81. (in Russian)]

4. Sobel J.D. Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis. Patient Prefer. Adherence. 2014; 8: 31-4.

5. Березовская Е.С., Макарова И.О., Гомберг М.А., Боровкова Е.И., Чулкова Е.А., Аракелян Е.А. Биопленки при бактераильном вагинозе. Акушерство, гинекология и репродукция. 2013; 7(2): 34-6. [Berezovskaya E.S., Makarova I.O., Gomberg M.A., Borovkova E.I., Chulkova E.A., Arakelyan E.A. Biofilms in bactereactive vaginosis. Obstetrics, gynecology and reproduction. 2013; 7 (2): 34-6. (in Russian)]

6. Карасов И.А. Особенности взаимодействия грибов рода Candida с иммунокомпетентными клетками. Международный студенческий научный вестник. 2018; 1: 30-5. [Karasov I.A. Features of the interaction of fungi of the genus Candida with immunocompetent cells. International Student Science Journal. 2018; 1: 30-5. (in Russian)]

7. Кузнецова И.В. Бактериальный вагиноз и вульвовагинальный кандидоз: оптимальные схемы лечения больных с сочетанной инфекцией. Российский вестник акушера-гинеколога. 2013; 13(3): 42-6. [Kuznetsova I.V. Bacterial vaginosis and vulvovaginal candidiasis: optimal treatment regimens for patients with co-infection. Russian Bulletin of the obstetrician-gynecologist. 2013; 13 (3): 42-6. (in Russian)]

8. Галанова В.Ю., Карасов И.А. Современные представления о вульвовагинальных кандидозах. Международный студенческий научный вестник. 2018; 6: 40-3. [Galanova V.Yu., Karasov I.A. Modern ideas about vulvovaginal candidiasis. International Student Science Journal. 2018; 6: 40-3. (in Russian)]

9. Cassone A. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG. 2015; 122(6): 785-94.

10. Carrillo-Muñoz A.J., Tur-Tur C., Giusiano G., Marcos-Arias C., Eraso E., Jauregizar N., Quindós G. Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis. Expert Rev. Anti Infect. Ther. 2013; 11(4): 347-58.

11. Мальбахова Е.Г., Арзуманян В.Г. Современный взгляд на проблему диагностики и лечения вульвовагинального кандидоза. Вестник дерматологии и венерологии. 2015; 2: 111-5. [Malbakhova E.G., Arzumanyan V.G. Modern view on the problem of diagnosis and treatment of vulvovaginal candidiasis. Bulletin of dermatology and venereology. 2015; 2: 111-5. (in Russian)]

12. Gow N., Netea M. Medical mycology and fungal immunology: new research perspectives addressing a major world health challenge. Philos. Trans. R Soc. Lond. B Biol. Sci. 2016; 371(1709). pii: 20150462.

13. Perfect J.R. Fungal diagnosis: how do we do it and can we do better? Curr. Med. Res. Opin. 2013; 29(Suppl. 4): 3-11.

14. Пашинина О.А., Карташова О.Л., Пашкова Т.М., Попова Л.П. Антимикотикорезистентность грибов рода Candida, выделенных из репродуктивного тракта женщин с воспалительными заболеваниями гениталий. Бюллетень Оренбургского научного центра УрО РАН. 2016; 3: 9-10. [Pashinina O.A, Kartashova O.L, Pashkova T.M, Popova L.P. Antimycotic resistance of Candida fungi isolated from the reproductive tract of women with inflammatory diseases of the genitals. Bulletin of the Orenburg Scientific Center UB RAS. 2016; 3: 9-10. (in Russian)]

15. Denning D., Perlin D., Muldoon E., Colombo A., Chakrabarti A., Richardson M., Sorrell T. Delivering on antimicrobial resistance agenda not possible without improving fungal diagnostic capabilities. Emerg. Infect. Dis. 2017;23(2): 177-83.

Received 30.11.2018

Accepted 07.12.2018

About the Authors

Strizhakov, Alexander N., MD academician of the Russian Academy of Sciences, professor, head of the Department of Obstetrics, Gynecology and Perinatology, Medical Faculty, I.M. Sechenov First Moscow State Medical University (Sechenov University).
119991, Russia, Moscow, Trubetskaya str. 8, bldg. 2. Tel.: +74997823045. E-mail: kafedra-agp@mail.ru. Scopus ID 7005104683
Ignatko, Irina V., MD, corresponding member of the Russian Academy of Sciences, professor of the Department of Obstetrics, Gynecology and Perinatology, Medical Faculty,
I.M. Sechenov First Moscow State Medical University (Sechenov University).
119991, Russia, Moscow, Trubetskaya str. 8, bldg. 2. Tel.: +74997823045. E-mail: iradocent@mail.ru. ORCID 0000-0002-9945-3848. Scopus ID 15118951800
Churganova, Anastasia A., PhD, assistant of the Department of Obstetrics, Gynecology and Perinatology, Medical Faculty, I.M. Sechenov
First Moscow State Medical University (Sechenov University).
119991, Russia, Moscow, Trubetskaya str. 8, bldg. 2.Tel.: +74997823045. E-mail: churganova1@rambler.ru. ORCID 0000–0001-9398-9900. Scopus ID 57194097924
Bogacheva, Natalia A., PhD, assistant of the Department of Obstetrics, Gynecology and Perinatology, Medical Faculty, I.M. Sechenov First Moscow State Medical University (Sechenov University). 119991, Russia, Moscow, Trubetskaya str. 8, bldg. 2. Tel.: +74997823045. E-mail: kafedra-agp@mail.ru

For citations: Strizhakov A.N., Ignatko I.V., Churganova A.A., Bogacheva N.A. Improved approaches in the treatment of complicated bacterial vaginosis and vulvovaginal candidiasis.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2018; (12): 142-8. (in Russian)
http://dx.doi.org/10.18565/aig.2018.12.142-148

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.